Research output

  1. Efficacy of nivolumab (Nivo) during 2+ line treatment and quality of life in patients with advanced refractory non-small cell lung cancer: Interim results of prospective observational study

    Research output: Contribution to journal › Article › peer-review

View all (1) »

ID: 223433